What Is Recent in Pancreatic Cancer Immunotherapy?

What Is Recent in Pancreatic Cancer Immunotherapy?

Pancreatic cancer (PC) represents an unresolved therapeutic challenge, due to the poor prognosis and the reduced response to currently available treatments. Pancreatic cancer is the most lethal type of digestive cancers, with a median survival of 4–6 months. Only a small proportion of PC patients is...

Full description

Bibliographic Details
Main Authors:	Elena Niccolai, Domenico Prisco, Mario Milco D'Elios, Amedeo Amedei
Format:	Article
Language:	English
Published:	Hindawi Limited 2013-01-01
Series:	BioMed Research International
Online Access:	http://dx.doi.org/10.1155/2013/492372

Similar Items

T Cells and Adoptive Immunotherapy: Recent Developments and Future Prospects in Gastrointestinal Oncology
by: Amedeo Amedei, et al.
Published: (2011-01-01)

Multiple Sclerosis: The Role of Cytokines in Pathogenesis and in Therapies
by: Mario Milco D’Elios, et al.
Published: (2012-10-01)

T Cells in Gastric Cancer: Friends or Foes
by: Amedeo Amedei, et al.
Published: (2012-01-01)

Novel Immunotherapeutic Strategies of Gastric Cancer Treatment
by: Amedeo Amedei, et al.
Published: (2011-01-01)

The Janus-Faced Role of Cell-Mediated Immune Responses in Pancreatic Cancer
by: Elena Niccolai, et al.
Published: (2017-10-01)

Editorial: Immune Checkpoint Molecules and Cancer Immunotherapy
by: Alexandr V. Bazhin, et al.
Published: (2018-12-01)

An Approach to Differential Diagnosis of Antiphospholipid Antibody Syndrome and Related Conditions
by: Giacomo Emmi, et al.
Published: (2014-01-01)

Editorial: Gut Microbiota and Inflammation: Relevance in Cancer and Cardiovascular Disease
by: Cinzia Parolini, et al.
Published: (2020-12-01)

The Gut–Brain Axis in the Neuropsychological Disease Model of Obesity: A Classical Movie Revised by the Emerging Director “Microbiome”
by: Elena Niccolai, et al.
Published: (2019-01-01)

HP0175 Promotes the Production of IL-23, IL-6, IL-1β and TGF-β
by: A. Amedei, et al.
Published: (2013-01-01)

Potential role of M. tuberculosis specific IFN-γ and IL-2 ELISPOT assays in discriminating children with active or latent tuberculosis.
by: Elena Chiappini, et al.
Published: (2012-01-01)

Cytotoxic T Cells in H. pylori-Related Gastric Autoimmunity and Gastric Lymphoma
by: Mathijs P. Bergman, et al.
Published: (2010-01-01)

Recent Advances in Cancer Immunotherapy
by: Kenichi Suda
Published: (2021-02-01)

Recent advances in cancer immunotherapy
by: Weijing Sun
Published: (2017-04-01)

Recent advances in cancer immunotherapy
by: Qiang Sun, et al.
Published: (2021-08-01)

Significant and Conflicting Correlation of IL-9 With Prevotella and Bacteroides in Human Colorectal Cancer
by: Elena Niccolai, et al.
Published: (2021-01-01)

Exosomes and the Future of Immunotherapy in Pancreatic Cancer
by: Ines A. Batista, et al.
Published: (2019-01-01)

LMW-PTP targeting potentiates the effects of drugs used in chronic lymphocytic leukemia therapy
by: Nagaja Capitani, et al.
Published: (2019-03-01)

Pancreatic Cancer and Immunotherapy: A Clinical Overview
by: Florentine E. F. Timmer, et al.
Published: (2021-08-01)

PD-1 immunotherapy in pancreatic cancer: current status
by: Ning Pu, MD, et al.
Published: (2019-03-01)

Immunotherapy updates in pancreatic cancer: are we there yet?
by: Krishna Soujanya Gunturu, et al.
Published: (2013-01-01)

Combination Immunotherapy Approaches for Pancreatic Cancer Treatment
by: Xianliang Cheng, et al.
Published: (2018-01-01)

Challenges and Future Perspectives of Immunotherapy in Pancreatic Cancer
by: Anna Maxi Wandmacher, et al.
Published: (2021-08-01)

Acquired resistance to immunotherapy in MMR-D pancreatic cancer
by: Zishuo Ian Hu, et al.
Published: (2018-11-01)

The Different Functional Distribution of “Not Effector” T Cells (Treg/Tnull) in Colorectal Cancer
by: Elena Niccolai, et al.
Published: (2017-12-01)

Immune Landscape in Tumor Microenvironment: Implications for Biomarker Development and Immunotherapy
by: Karim Pérez-Romero, et al.
Published: (2020-08-01)

Update on the challenges and recent advances in cancer immunotherapy
by: Baronzio G, et al.
Published: (2013-06-01)

Recent development and applications of nanomaterials for cancer immunotherapy
by: Huang Yao, et al.
Published: (2020-04-01)

Immunotherapy in urothelial cancer: recent data and perspectives
by: M. I. Volkova, et al.
Published: (2018-01-01)

Novel M. tuberculosis specific IL-2 ELISpot assay discriminates adult patients with active or latent tuberculosis.
by: Chiara Della Bella, et al.
Published: (2018-01-01)

Immunotherapy and pancreatic cancer: unique challenges and potential opportunities
by: Kate Young, et al.
Published: (2018-12-01)

Immunotherapy in pancreatic cancer treatment: a new frontier
by: Komal Thind, et al.
Published: (2017-01-01)

Immunotherapy on Pancreatic Cancer: Current Status and Future Perspectives
by: JIN Xin, et al.
Published: (2020-03-01)

Pancreatic cancer as a target for adoptive T-cell immunotherapy
by: Anderson, John Edward
Published: (2007)

Circulating miRNome profiling data in Behçet's syndrome
by: Giacomo Bagni, et al.
Published: (2021-10-01)

Immunotherapy in Prostate Cancer: Recent Advances and Future Directions
by: Ida Silvestri, et al.
Published: (2019-05-01)

Recent Advances in Cancer Stem Cell-Targeted Immunotherapy
by: Narayanasamy Badrinath, et al.
Published: (2019-03-01)

Recent Progress in Dendritic Cell-Based Cancer Immunotherapy
by: Kazuhiko Matsuo, et al.
Published: (2021-05-01)

Precision Immuno-Oncology: Prospects of Individualized Immunotherapy for Pancreatic Cancer
by: Jiajia Zhang, et al.
Published: (2018-01-01)

Immunotherapy in Adolescents and Young Adults: What Remains in Cancer Survivors?
by: Enrica Teresa Tanda, et al.
Published: (2021-09-01)